661472-41-9

661472-41-9 structure

Name: Relamorelin
Chemical Name: Relamorelin
CAS Number: 661472-41-9
Molecular Formula: C₄₃H₅₀N₈O₅S
Molecular Weight: 790.973
Catalog: Signaling Pathways GPCR/G Protein GHSR
Create Date: 2018-06-13 08:15:35
Modify Date: 2024-01-05 14:40:02
Relamorelin (RM-131), a Ghrelin analog, is a potent ghrelin receptor agonist, with a Ki of 0.42 nM for GHS-1a. Relamorelin can promote food intake and adiposity in mice. Relamorelin can be used for the research of cachexia, gastroparesis, and gastric/intestinal dysmobility disorders[1][2][3].

Name	Relamorelin
Synonyms	3-(1-Benzothiophen-3-yl)-N-(4-piperidinylcarbonyl)-D-alanyltryptophyl-N-(4-carbamoyl-4-piperidinyl)phenylalaninamide Phenylalaninamide, 3-benzo[b]thien-3-yl-N-(4-piperidinylcarbonyl)-D-alanyltryptophyl-N-[4-(aminocarbonyl)-4-piperidinyl]- Relamorelin UNII-BIW199E18V BIW199E18V [3-(1-benzothiophen-3-yl)-N-(piperidin-4-ylcarbonyl)-D-alanyl]-D-tryptophyl-L-phenylalanyl-(4-aminopiperidine-4-carboxamide) 3-(1-Benzothiophen-3-yl)-N-(4-piperidinylcarbonyl)-D-alanyl-D-tryptophyl-N-(4-carbamoyl-4-piperidinyl)-L-phenylalaninamide L-Phenylalaninamide, 3-benzo[b]thien-3-yl-N-(4-piperidinylcarbonyl)-D-alanyl-D-tryptophyl-N-[4-(aminocarbonyl)-4-piperidinyl]-

Description	Relamorelin (RM-131), a Ghrelin analog, is a potent ghrelin receptor agonist, with a Ki of 0.42 nM for GHS-1a. Relamorelin can promote food intake and adiposity in mice. Relamorelin can be used for the research of cachexia, gastroparesis, and gastric/intestinal dysmobility disorders[1][2][3].
Related Catalog	Research Areas >> Metabolic Disease Signaling Pathways >> GPCR/G Protein >> GHSR
Target	Ki: 0.42 nM (GHS-1a)[1]
In Vitro	Relamorelin shows ∼3 times greater affinity for GHS-1a (Ki=0.42 nM) than native ghrelin (Ki=1. 12 nM)[1]. Relamorelin is 6 times more potent (EC50=0.71 nM) in activating the GHS-1a receptor than native ghrelin (EC50=4.2 nM) as assessed in vitro by calcium mobilization[1].
In Vivo	Relamorelin (500 nmol/kg/day; continuous infusion for 5 days) increases the food intake and weight gain in rats[1]. Relamorelin (50-500 nmol/kg/day; continuous infusion for 5 days) decreases the loss of body mass and fat mass[1]. RM-131 (250-500 nmol/kg; a single s.c.) stimulates acute food intake in wt but not growth hormone secretagogue receptor (GHR) ko mice[2]. Animal Model: F344/NTacfBR male rats implanted with tumor[1] Dosage: 50, 500 nmol/kg/day Administration: Continuous infusion at a rate of 0.5 μL/h for 5 d s.c. Result: Resulted in an increase in food intake (tumor/saline 41.4 g, tumor/BIM-28131 72.5 g) and weight gain (tumor/saline -10.3%, tumor/BIM-28131 +19.5%).
References	[1]. DeBoer MD, et, al. Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology. 2007 Jun;148(6):3004-12. [2]. Fischer K, et, al. The Pentapeptide RM-131 Promotes Food Intake and Adiposity in Wildtype Mice but Not in Mice Lacking the Ghrelin Receptor. Front Nutr. 2015 Jan 12;1:31. [3]. Zatorski H, et, al. Relamorelin and other ghrelin receptor agonists - future options for gastroparesis, functional dyspepsia and proton pump inhibitors-resistant non-erosive reflux disease. J Physiol Pharmacol. 2017 Dec;68(6):797-805.

Density	1.4±0.1 g/cm3
Boiling Point	1216.2±65.0 °C at 760 mmHg
Molecular Formula	C₄₃H₅₀N₈O₅S
Molecular Weight	790.973
Flash Point	689.3±34.3 °C
Exact Mass	790.362488
LogP	5.22
Vapour Pressure	0.0±0.3 mmHg at 25°C
Index of Refraction	1.692

661472-41-9	1809080-14-5
1158522-08-7	940364-43-2
134104-43-1	131615-57-1
6906-52-1	930439-75-1
1018584-77-4	1375289-11-4
849349-65-1	127437-46-1